Skip to main content
Drug Wars
  • Robin Feldman, University of California Hastings College of Law , Evan Frondorf, University of California Hastings College of Law

  • Publisher: Cambridge University Press
  • Target online publication date: June 2017
  • Print publication year: 2017
  • Online ISBN: 9781316717424
  • Book DOI:
  • Export citation
  • Recommend to librarian
  • Recommend this book

    Email your librarian or administrator to recommend adding this book to your organisation's collection.

    Drug Wars
    • Online ISBN: 9781316717424
    • Book DOI:
    Please enter your name
    Please enter a valid email address
    Who would you like to send this to? *
  • Buy the print book

Book description

While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.


Advance priase:'An important book and a compelling read. The authors show how pharmaceutical companies have twisted a law designed to protect invention into a regulatory nightmare that only protects profits.'

Mark A. Lemley - William H. Neukom Professor, Stanford Law School, California

Advance praise:'A fascinating and incisive study of the inner world of the pharmaceutical industry. A must read for anyone interested in the relationship between drug pricing, regulation, and its impact on public health.'

Sonia K. Katyal - Chancellor's Professor of Law, University of California, Berkeley